54
Views
8
CrossRef citations to date
0
Altmetric
Research Article

New in-situ gelling biopolymer-based matrix for bioavailability enhancement of glimepiride; in-vitro/in-vivo x-ray imaging and pharmacodynamic evaluations

, &
Pages 539-549 | Received 21 Feb 2018, Accepted 24 Aug 2018, Published online: 27 Sep 2018

References

  • Ammar H, Salama H, Ghorab M, Mahmoud A. 2006. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems. Int J Pharm. 309:129–138.
  • Anal AK, Tobiassen A, Flanagan J, Singh H. 2008. Preparation and characterization of nanoparticles formed by chitosan-caseinate interactions. Colloids Surf B Biointerfaces. 64:104–110.
  • Basalious EB, Abdullah A, Ibrahim M. 2014. Utility of mannitol and citric acid for enhancing the solubilizing and taste masking properties of β-cyclodextrin: development of fast-dissolving tablets containing extremely bitter drug. J Pharm Innov. 9:309–320.
  • Bernkop-Schnürch A, Dünnhaupt S. 2012. Chitosan-based drug delivery systems. Eur J Pharm Biopharm. 81:463–469.
  • Bhattarai N, Gunn J, Zhang M. 2010. Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev. 62:83–99.
  • Carr RL. 1965. Classifying flow properties of solids. Chem Eng. 72:69–72.
  • Chandiran IS, Kumar BP, Jayaveera KN. 2013. Design and development of microparticulate drug delivery system of glimepiride for controlled release. Drug Invent Today. 5:235–240.
  • Chaudhari MD, Sonawane RO, Zawar L, Nayak S, Bari SB. 2012. Solubility and dissolution enhancement of poorly water soluble glimepiride by using solid dispersion technique. Int J Pharm Pharm Sci. 4:534–539.
  • Cho HJ, Balakrishnan P, Park EK, Song KW, Hong SS, Jang TY, Kim KS, Chung SJ, Shim CK, Kim DD. 2011. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride. J Pharm Sci. 100:681–691.
  • Crowley SV, Gazi I, Kelly AL, Huppertz T, O’mahony JA. 2014. Influence of protein concentration on the physical characteristics and flow properties of milk protein concentrate powders. J Food Eng. 135:31–38.
  • Dhanasingh S, Nallaperumal SK. 2010. Chitosan/casein microparticles: preparation, characterization and drug release studies. World Acad Sci Eng Technol. 4:476–480.
  • Dorożyński P, Jachowicz R, Kulinowski P, Kwieciński S, Szybiński K, Skorka T, Jasiński A. 2004. The macromolecular polymers for the preparation of hydrodynamically balanced systems—methods of evaluation. Drug Dev Ind Pharm. 30:947–957.
  • Dudhani AR, Kosaraju SL. 2010. Bioadhesive chitosan nanoparticles: preparation and characterization. Carbohydr Polym. 81:243–251.
  • El-Hadidy GN, Ibrahim HK, Mohamed MI, El-Milligi MF. 2012. Microemulsions as vehicles for topical administration of voriconazole: formulation and in-vitro evaluation. Drug Dev Ind Pharm. 38:64–72.
  • El-Hefian EA, Yahaya AH. 2010. Rheological study of chitosan and its blends: an overview. Maejo Int J Sci Technol. 4:210–220.
  • El-Samaligy M, Yahia S, Basalious E. 2004. Formulation and evaluation of diclofenac sodium buccoadhesive discs. Int J Pharm. 286:27–39.
  • Elzoghby AO, El-Fotoh WSA, Elgindy NA. 2011. Casein-based formulations as promising controlled release drug delivery systems. J Control Release. 153:206–216.
  • Elzoghby AO, Samy WM, Elgindy NA. 2013. Novel spray-dried genipin-crosslinked casein nanoparticles for prolonged release of alfuzosin hydrochloride. Pharm Res. 30:512–522.
  • Elzoghby AO, Vranic BZ, Samy WM, Elgindy NA. 2015. Swellable floating tablet based on spray-dried casein nanoparticles: near-infrared spectral characterization and floating matrix evaluation. Int J Pharm. 491:113–122.
  • Elzoghby AO, Helmy MW, Samy WM, Elgindy NA. 2013. Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics. Int J Nanomedicine. 8:1721–1732.
  • Gupta S, Vyas SP. 2010. Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate. Sci Pharm. 78:959–976.
  • Hausner H. 1967. Friction conditions in a mass of metal powder. Int J Powder Met. 3:7–13.
  • Higuchi T. 1963. Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 52:1145–1149.
  • Jain S, Yadav S, Patil U. 2008. Preparation and evaluation of sustained release matrix tablet of furosemide using natural polymers. RJPT. 1:374–376.
  • Kaur L, Bala R, Kanojia N, Nagpal M, Dhingra GA. 2014. Formulation development and optimization of fast dissolving tablets of aceclofenac using natural superdisintegrant. ISRN Pharmaceutics. 2014:1.
  • Martin A, Bustamante P, Chun AHC. 2011. Chemical kinetics and Stability, Chapter 14. In: Sinko PJ, Singh Y, editor(s). Martin’s Physical Pharmacy and pharmaceutical sciences. 6th Ed. Philadelphia (USA): Lippincott Williams & Wilkins. p. 318–354.
  • Mehta A, Vasanti S, Tyagi R, Shukla A. 2009. Formulation and evaluation of solid dispersion of an antidiabetic drug. Curr Trends Biotech Pharm. 3:76–84.
  • Mohamed EA, Meshali MM, Foda AMM, Borg TM. 2012. Improvement of dissolution and hypoglycemic efficacy of glimepiride by different carriers. AAPS PharmSciTech. 13:1013–1023.
  • Mohd AB, Sanka K, Bandi S, Diwan PV, Shastri N. 2015. solid self-nanoemulsifying drug delivery system (s-snedds) for oral delivery of glimepiride: development and antidiabetic activity in albino rabbits. Drug Deliv. 22:499–508.
  • Nagendra R, Pai RS, Singh G. 2014. Design and optimization of novel in-situ gel of mercaptopurine for sustained drug delivery. Braz J Pharm Sci. 50:107–119.
  • Nilsen-Nygaard J, Strand SP, Vårum KM, Draget KI, Nordgård CT. 2015. Chitosan: gels and interfacial properties. Polymers. 7:552–579.
  • Pabari R, Ramtoola Z. 2012. Effect of a disintegration mechanism on wetting, water absorption, and disintegration time of orodispersible tablets. J Young Pharm. 4:157–163.
  • Park JS, Shim JY, Truong NKV, Park JS, Shin S, Choi YW, Lee J, Yoon JH, Jeong SH. 2010. A pharma-robust design method to investigate the effect of PEG and PEO on matrix tablets. Int J Pharm. 393:79–87.
  • Peppas N. 1985. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 60:110–111.
  • Peppas NA. 1983. A model of dissolution‐controlled solute release from porous drug delivery polymeric systems. J Biomed Mater Res. 17:1079–1087.
  • Prajapati VD, Jani GK, Khutliwala TA, Zala BS. 2013. Raft forming system-an upcoming approach of gastroretentive drug delivery system. J Control Release. 168:151–165.
  • Rajinikanth P, Balasubramaniam J, Mishra B. 2007. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori. Int J Pharm. 335:114–122.
  • Razmi M, Divsalar A, Saboury AA, Izadi Z, Haertlé T, Mansuri-Torshizi H. 2013. Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug. Colloids Surf B Biointerfaces. 112:362–367.
  • Reichal CR, Lakshmi JB, Ravi T. 2011. Studies on formulation and in vitro evaluation of glimepiride floating tablets. J Chem Pharm Res. 3:159–164.
  • Samy W, Elgindy N, El-Gowelli HM. 2012. Biopolymeric nifedipine powder for acceleration of wound healing. Int J Pharm. 422:323–331.
  • Shah NV, Seth AK, Balaraman R, Aundhia CJ, Maheshwari RA, Parmar GR. 2016. Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: design and in vivo study. J Adv Res. 7:423–434.
  • Shaji J, Jain V, Lodha S. 2010. Chitosan: a novel pharmaceutical excipient. Int J Pharm Appl Sci. 1:11–28.
  • Siepmann J, Peppas N. 2001. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 48:139–157.
  • Silva JV, O'mahony JA. 2017. Flowability and wetting behaviour of milk protein ingredients as influenced by powder composition, particle size and microstructure. Int J Dairy Technol. 70:277–286.
  • Tadros MI. 2010. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers . Eur J Pharm Biopharm. 74:332–339.
  • Tapia C, Corbalan V, Costa E, Gai MN, Yazdani-Pedram M. 2005. Study of the release mechanism of diltiazem hydrochloride from matrices based on chitosan − alginate and chitosan − carrageenan mixtures. Biomacromolecules. 6:2389–2395.
  • Temesgen A, Belete A, Gebre-Mariam T. 2016. Preparation and in vitro evaluation of in-situ gelling gastroretentive salbutamol sulfate liquid formulations. Int J Pharm Sci Res. 7:93–01.
  • USP. The United States Pharmacopeia 40th Revision, 2017, The United States Pharmacopeial Convention 12601 Twinbrook parkway, Rockville, MD 20852.
  • Zaki NM, Awad GA, Mortada ND, Elhady SSA. 2007. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in-situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci. 32:296–307.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.